2020 Best of Breast


 

Treatment of 57 y/o Post-Menopausal Woman With HER2+ Breast Cancer - Options for Early Stage Disease: Discussing Data on Paclitaxel/Trastuzumab, T-DM1, & Pertuzumab and Trastuzumab

951 views
March 2, 2020
Comments 0
Login to view comments. Click here to Login